Sign in to view content

ZETA-1 Phase 2 Trial Efficacy Results for APX3330 a Novel Oral Ref-1 Inhibitor for the Treatment of Diabetic Retinopathy

David R Lally, MD

Video
Published 2023

Related

Diabetic Traction and Rhegmatogenous Retinal Detachment 27-Gauge Vitrectomy
Maria H. Berrocal, MD
Innovative Retina Surgical Video Series
2014
Does the Diabetic Status Influence the Rate of Cataract Surgery Following Pars Plana Vitrectomy Surgery?
Ahmed Sallam, MD PhD FRCOphth
On Demand Cases, Courses, and Papers
2019
National Cohort Study on New Oral Hypoglycemic Agents in Diabetic Retinopathy Progression
Ehsan Rahimy, MD
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more